Early functional change in macular disease often precedes visible structural damage. Retimax enables clinicians to detect these subtle alterations through objective electrophysiological testing, including multifocal electroretinogram, pattern electroretinogram, and visual evoked potentials testing.
Published clinical studies have shown that biofeedback training with Retimax can significantly improve best-corrected visual acuity, contrast sensitivity and fixation stability in patients with macular degeneration, while also enhancing reading performance and quality of life.1
For practices focused on proactive care, the real advantage lies in earlier detection and intervention – identifying macular dysfunction before optical coherence tomography changes become pronounced. This allows timely referral, closer monitoring, and improved patient outcomes. By combining diagnostic precision with evidence-based visual rehabilitation, Retimax positions practices at the forefront of functional retinal assessment and modern low-vision management.
Visit: eyetek.com.au
Reference
- Verdina T, Piaggi S, Cavallini GM. Seminars in Ophthalmology, doi: 10.1080/08820538.2020.1774624.
